vs

Side-by-side financial comparison of Genius Sports Ltd (GENI) and Playtika Holding Corp. (PLTK). Click either name above to swap in a different company.

Playtika Holding Corp. is the larger business by last-quarter revenue ($744.7M vs $510.9M, roughly 1.5× Genius Sports Ltd). Playtika Holding Corp. runs the higher net margin — -7.7% vs -12.3%, a 4.6% gap on every dollar of revenue. Genius Sports Ltd produced more free cash flow last quarter ($69.6M vs $2.6M). Over the past eight quarters, Genius Sports Ltd's revenue compounded faster (129.2% CAGR vs 9.0%).

Genius Sports is a sports data and technology company that provides data management, video streaming and integrity services to sports leagues, bookmakers and media companies.

Playtika Holding Corp. is an Israeli digital entertainment company specializing in the development and publication of mobile games. In 2021, Playtika had over 35 million monthly active users.

GENI vs PLTK — Head-to-Head

Bigger by revenue
PLTK
PLTK
1.5× larger
PLTK
$744.7M
$510.9M
GENI
Higher net margin
PLTK
PLTK
4.6% more per $
PLTK
-7.7%
-12.3%
GENI
More free cash flow
GENI
GENI
$67.0M more FCF
GENI
$69.6M
$2.6M
PLTK
Faster 2-yr revenue CAGR
GENI
GENI
Annualised
GENI
129.2%
9.0%
PLTK

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
GENI
GENI
PLTK
PLTK
Revenue
$510.9M
$744.7M
Net Profit
$-63.0M
$-57.5M
Gross Margin
25.2%
74.2%
Operating Margin
-11.5%
-6.7%
Net Margin
-12.3%
-7.7%
Revenue YoY
5.5%
Net Profit YoY
-287.9%
EPS (diluted)
$-0.15

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GENI
GENI
PLTK
PLTK
Q1 26
$744.7M
Q4 25
$510.9M
$678.8M
Q3 25
$335.4M
$674.6M
Q2 25
$215.2M
$696.0M
Q1 25
$119.7M
$706.0M
Q4 24
$413.0M
$650.3M
Q3 24
$285.8M
$620.8M
Q2 24
$184.1M
$627.0M
Net Profit
GENI
GENI
PLTK
PLTK
Q1 26
$-57.5M
Q4 25
$-63.0M
$-309.3M
Q3 25
$39.1M
Q2 25
$-47.3M
$33.2M
Q1 25
$-25.5M
$30.6M
Q4 24
$-85.5M
$-16.7M
Q3 24
$-47.1M
$39.3M
Q2 24
$-35.5M
$86.6M
Gross Margin
GENI
GENI
PLTK
PLTK
Q1 26
74.2%
Q4 25
25.2%
72.5%
Q3 25
24.2%
73.6%
Q2 25
19.1%
71.9%
Q1 25
10.7%
72.0%
Q4 24
16.7%
72.5%
Q3 24
20.5%
72.9%
Q2 24
18.6%
73.2%
Operating Margin
GENI
GENI
PLTK
PLTK
Q1 26
-6.7%
Q4 25
-11.5%
-41.4%
Q3 25
-15.3%
14.6%
Q2 25
-21.0%
15.8%
Q1 25
-20.3%
9.6%
Q4 24
-18.0%
8.5%
Q3 24
-13.9%
15.7%
Q2 24
-16.8%
22.4%
Net Margin
GENI
GENI
PLTK
PLTK
Q1 26
-7.7%
Q4 25
-12.3%
-45.6%
Q3 25
5.8%
Q2 25
-22.0%
4.8%
Q1 25
-21.3%
4.3%
Q4 24
-20.7%
-2.6%
Q3 24
-16.5%
6.3%
Q2 24
-19.3%
13.8%
EPS (diluted)
GENI
GENI
PLTK
PLTK
Q1 26
$-0.15
Q4 25
$-0.83
Q3 25
$0.11
Q2 25
$0.09
Q1 25
$0.08
Q4 24
$-0.04
Q3 24
$0.11
Q2 24
$0.23

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GENI
GENI
PLTK
PLTK
Cash + ST InvestmentsLiquidity on hand
$280.6M
$779.2M
Total DebtLower is stronger
$2.4B
Stockholders' EquityBook value
$724.5M
Total Assets
$1.1B
$3.7B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GENI
GENI
PLTK
PLTK
Q1 26
$779.2M
Q4 25
$280.6M
$684.2M
Q3 25
$110.2M
$587.9M
Q2 25
$110.2M
$500.9M
Q1 25
$110.2M
$434.8M
Q4 24
$100.3M
$565.8M
Q3 24
$100.3M
$1.1B
Q2 24
$100.3M
$710.3M
Total Debt
GENI
GENI
PLTK
PLTK
Q1 26
$2.4B
Q4 25
$2.4B
Q3 25
$2.4B
Q2 25
$2.4B
Q1 25
$2.4B
Q4 24
$2.4B
Q3 24
$2.4B
Q2 24
$2.4B
Stockholders' Equity
GENI
GENI
PLTK
PLTK
Q1 26
Q4 25
$724.5M
$-411.4M
Q3 25
$572.4M
$-74.8M
Q2 25
$572.4M
$-87.8M
Q1 25
$572.4M
$-117.2M
Q4 24
$573.0M
$-131.1M
Q3 24
$573.0M
$-98.0M
Q2 24
$573.0M
$-112.9M
Total Assets
GENI
GENI
PLTK
PLTK
Q1 26
$3.7B
Q4 25
$1.1B
$3.7B
Q3 25
$792.3M
$3.7B
Q2 25
$792.3M
$3.6B
Q1 25
$792.3M
$3.6B
Q4 24
$775.7M
$3.6B
Q3 24
$775.7M
$3.2B
Q2 24
$775.7M
$3.2B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GENI
GENI
PLTK
PLTK
Operating Cash FlowLast quarter
$81.9M
Free Cash FlowOCF − Capex
$69.6M
$2.6M
FCF MarginFCF / Revenue
13.6%
0.3%
Capex IntensityCapex / Revenue
2.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$33.5M
$525.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GENI
GENI
PLTK
PLTK
Q1 26
Q4 25
$81.9M
$285.9M
Q3 25
$-4.8M
$116.9M
Q2 25
$-1.2M
$146.1M
Q1 25
$-14.6M
$18.8M
Q4 24
$14.9M
$153.1M
Q3 24
$-9.2M
$156.9M
Q2 24
$150.5M
Free Cash Flow
GENI
GENI
PLTK
PLTK
Q1 26
$2.6M
Q4 25
$69.6M
$275.2M
Q3 25
$-14.2M
$106.5M
Q2 25
$-5.8M
$141.3M
Q1 25
$-16.0M
$8.4M
Q4 24
$11.3M
$140.3M
Q3 24
$-11.6M
$152.1M
Q2 24
$141.2M
FCF Margin
GENI
GENI
PLTK
PLTK
Q1 26
0.3%
Q4 25
13.6%
40.5%
Q3 25
-4.2%
15.8%
Q2 25
-2.7%
20.3%
Q1 25
-13.4%
1.2%
Q4 24
2.7%
21.6%
Q3 24
-4.1%
24.5%
Q2 24
22.5%
Capex Intensity
GENI
GENI
PLTK
PLTK
Q1 26
Q4 25
2.4%
1.6%
Q3 25
2.8%
1.5%
Q2 25
2.1%
0.7%
Q1 25
1.2%
1.5%
Q4 24
0.9%
2.0%
Q3 24
0.9%
0.8%
Q2 24
1.5%
Cash Conversion
GENI
GENI
PLTK
PLTK
Q1 26
Q4 25
Q3 25
2.99×
Q2 25
4.40×
Q1 25
0.61×
Q4 24
Q3 24
3.99×
Q2 24
1.74×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons